# The Efficacy and Mechanism of Trientine in Patients With Hypertrophic Cardiomyopathy

Study · id `cardio:ct-nct04706429` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04706429](<https://clinicaltrials.gov/study/NCT04706429>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT04706429

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 154 participants.

## Technical summary

Registry record NCT04706429. Randomized; quadruple masking; primary purpose treatment. Start 2020-12-01 (actual); primary completion 2024-04-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 154 participants (enrolled count; ClinicalTrials.gov record NCT04706429, source copy `cardio:ctgov-nct04706429-2025-09-29`, retrieved 2026-10-31)
- Started: 2020-12-01 (actual) (ClinicalTrials.gov record NCT04706429, source copy `cardio:ctgov-nct04706429-2025-09-29`, retrieved 2026-10-31)
- Primary completion: 2024-04-30 (actual) (ClinicalTrials.gov record NCT04706429, source copy `cardio:ctgov-nct04706429-2025-09-29`, retrieved 2026-10-31)
- Completion: 2024-07-30 (actual) (ClinicalTrials.gov record NCT04706429, source copy `cardio:ctgov-nct04706429-2025-09-29`, retrieved 2026-10-31)
- Countries: United Kingdom (ClinicalTrials.gov record NCT04706429, source copy `cardio:ctgov-nct04706429-2025-09-29`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04706429-2025-09-29`, retrieved 2026-10-31)

## The registry's words

- Brief title: The Efficacy and Mechanism of Trientine in Patients With Hypertrophic Cardiomyopathy
- Acronym: TEMPEST
- Condition: Hypertrophic Cardiomyopathy
- Intervention (Drug): Trientine
- Intervention (Drug): Placebo
- Lead sponsor: Manchester University NHS Foundation Trust
- Lead sponsor class: OTHER\_GOV
- Collaborator: National Institute for Health Research, United Kingdom
- Collaborator class: OTHER\_GOV
- Collaborator: University of Manchester
- Collaborator class: OTHER
- Collaborator: University of Liverpool
- Collaborator class: OTHER
- Collaborator: Univar BV
- Collaborator class: INDUSTRY
- Collaborator: University of Oxford
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Cardiomyopathy (heart muscle disease) (`cardio:cardiomyopathy`)
- Registry condition terms include this condition: Hypertrophic cardiomyopathy (`cardio:hypertrophic-cardiomyopathy`)
- Registry lists this organization as the lead sponsor: Manchester University NHS Foundation Trust (`cardio:org-manchester-university-nhs-foundation-trust`)
- Registry lists this organization as a collaborator: National Institute for Health Research, United Kingdom (`cardio:org-national-institute-for-health-research-united-kingdom`)
- Registry lists this organization as a collaborator: University of Manchester (`cardio:org-university-of-manchester`)
- Registry lists this organization as a collaborator: University of Liverpool (`cardio:org-university-of-liverpool`)
- Registry lists this organization as a collaborator: University of Oxford (`cardio:org-university-of-oxford`)

## Provenance

Content hash: 9f346432ce1fb180d5aaf2cfd8558f1b426ce11bffe01200b5d14b0e0eefee18
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
